Aspergillus Nidulans in the CNS

Danny R. Gray DannyGray at
Mon Mar 10 18:56:11 EST 1997

This has been posted several times on this group in the past two months.

There have been some very good responses.  Please, READ the responses and
contact the person that posted them.

I understand that you are very concerned.  But, use the information given
before you autopost again.

PLEASE HELP <domflag at> wrote in article
<5g1h2l$e9e at>...
> We are the parents of a twenty month old Baby Boy with a life threatening
> disease.   To our knowledge this is the first case of a fungal infection
> this type known anywhere in the world.   If you can provide any
> for helping our little Boy we would be most grateful.
> Infection:   Aspergillus Nidulans in the Central Nervous System.  The
> fungus surrounds the base of the brain and is present in other locations
> the covering of the Meninges.   This was diagnosed following a biopsy
> from his lumbar region.  Biopsy was taken September 13, 1996.
> Cause of Infection:  Unknown
> Patient's Present Condition:  Beginning to show signs of Hydrocephalus.  
> Vomiting is becoming more frequent.   Fevers and pain becoming more
> frequent and severe.  He is developing a little trouble walking.
> Course of Treatment.   Began treatment in September on Amphotericin B and
> 5FC given by IV.  Treatment was determined to be unsuccessful.   After
> month MRI showed disease had progressed.
> The next treatment was Amphotericin Liposomal given by IV and Oral
> Itraconazole.   An MRI taken one month after this treatment was started
> appeared to show a slight reduction in the size of the fungal growths,
> however a followup MRI taken thirty days later showed the fungus was once
> again growing.   At this point the decision was made to put in a
> to administer Ampho B directly into his CSF.   On January 9, 1997 a
> biopsy was taken from his spine.   The biopsy confirmed the fungus was
> Aspergillus, but the cultures would not grow so it could not be confirmed
> the fungus was Nidulans.
> An MRI taken February 3, 1997 has shown that the fungus increased in size
> considerably even with this treatment and there are new lesions.
> The therapy is now going to be double the dose of Oral Itraconazole
> (10mg/kg) and the itrathecal Amphotericin therapy has been discontinued. 

> He is being given Gamma Interferon Sub-cutaneously to boost immune
> though no immune deficiency has ever been detected.   He had a negative
> result when tested for CGD.

More information about the Neur-sci mailing list